http://purl.uniprot.org/citations/34190995 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/34190995 | http://purl.org/dc/terms/identifier | "doi:10.1001/jamanetworkopen.2021.14904"xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/author | "Johansson A."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/author | "Benz C."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/author | "Yau C."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/author | "Nordenskjold A."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/author | "Dar H."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/author | "Nordenskjold B."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/author | "Stal O."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/author | "Fornander T."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/author | "Esserman L.J."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/author | "Perez-Tenorio G."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/author | "Lindstrom L.S."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/author | "Iftimi A."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/date | "2021"xsd:gYear |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/name | "JAMA Netw Open"xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/pages | "e2114904"xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/title | "Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial."xsd:string |
http://purl.uniprot.org/citations/34190995 | http://purl.uniprot.org/core/volume | "4"xsd:string |
http://purl.uniprot.org/citations/34190995 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/34190995 |
http://purl.uniprot.org/citations/34190995 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/34190995 |
http://purl.uniprot.org/uniprot/#_A0A125SXW0-mappedCitation-34190995 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34190995 |
http://purl.uniprot.org/uniprot/#_A0A125SXW1-mappedCitation-34190995 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34190995 |
http://purl.uniprot.org/uniprot/#_A0A125SXV8-mappedCitation-34190995 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34190995 |
http://purl.uniprot.org/uniprot/#_A0A125SXV9-mappedCitation-34190995 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34190995 |